




	
	  if (document.domain != 'www.netvibes.com') {	  
		  document.write(
'\n\t\n<style>\ndiv.vbp-widget * {\n    margin: 0;\n    padding: 0;\n    line-height:normal;\n    border:none;\n    text-transform:none;\n    \n}\n\ndiv.vbp-widget {\n    border: 1px solid #CCC;\n    color: #222;\n    margin: 0 auto;\n    background: #EEE;\n    font-family: \'Helvetica Neue\', Arial, sans-serif;\n    font-size: 12px;\n}\n\ndiv.vbp-widget a,\ndiv.vbp-widget a:link,\ndiv.vbp-widget a:visited {\n    text-decoration: none;\n    color: #35D;\n}\ndiv.vbp-widget a:hover {\n    text-decoration: underline;\n} \n\n/**** header ****/\n\ndiv.vbp-widget .vbp-header {\n    background: #DDD;\n    height: 44px;\n    border-bottom: 1px solid #BBB;\n    background: #DDD url(http://venturebeatprofiles.com/images/widget_bg.gif) repeat-x top left;\n    padding: 5px 15px;\n}\n\ndiv.vbp-widget p.vbp-company {\n    padding-top: 3px;\n    margin-right: 140px;\n    float: left;\n    padding-bottom:0;\n}\n\ndiv.vbp-widget .vbp-company a {\n}\ndiv.vbp-widget .vbp-company a * {\n    display: block;\n}\n\ndiv.vbp-widget .vbp-company a strong {\n    font-size: 18px;\n    color: #333;\n    text-shadow: 0 2px 1px #FFF;\n    font-weight: bold;\n}\ndiv.vbp-widget .vbp-company a em {\n    font-style: normal;\n    font-size: 11px;\n    color: #346;\n}\n\ndiv.vbp-widget a img {\n    border: none;\n}\n\ndiv.vbp-widget .vbp-header img, div.vbp-widget .vbp-header a img {\n    float: right;\n    border: 1px solid #CCC;\n}\n\ndiv.vbp-widget p.vbp-utility {\n    width: 120px;\n    float: right;\n    padding-bottom:0;\n}\n\ndiv.vbp-widget .vbp-utility a {\n    display: block;\n    padding: 2px 5px;\n    font-size: 11px;\n    -moz-border-radius: 3px;\n\t-webkit-border-radius: 3px;\n    margin-right: 5px;\n    margin-bottom: 3px;\n}\ndiv.vbp-widget .vbp-utility a:link,\ndiv.vbp-widget .vbp-utility a:visited {\n    background: rgba(0,0,0,.08);\n    color: #111;\n    text-shadow: 0 1px 1px hsla(0,0%,100%,1);\n}\ndiv.vbp-widget .vbp-utility a:hover {\n    background: #459;\n    color: #FFF;\n    text-decoration: none;\n    text-shadow: none;\n}\n\n/**** content ****/\n\ndiv.vbp-widget div.vbp-content {\n    padding: 8px 0;\nbackground-color:#fff;\n}\n\ndiv.vbp-widget .vbp-col {\n    width: 46%;\n    float: left;\n    margin: 0 2%;\n}\n\ndiv.vbp-widget div.vbp-content p,\ndiv.vbp-widget div.vbp-content h5 {\n    padding-left: 5px;\n}\n\ndiv.vbp-widget p {\n\tmargin-top: 0px;\n  font-size: 12px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-categogy {\n    clear: both;\n    margin-bottom: 10px;\n}\n\ndiv.vbp-widget div.vbp-content h5 {\n    font-size: 12.5px;\n    background: #F4F4F4;\n    color: #444;\n    padding-top: 2px;\n    padding-bottom: 2px;\n    background: #F4F4F4 url(http://venturebeatprofiles.com/images/widget_heading_bg.gif) repeat-x left bottom;\n}\n\ndiv.vbp-widget div.vbp-content div.vbp-category p {\n    border-top: 1px dotted #E4E4E4;\n    padding-top: 4px;\n    padding-bottom: 4px;\n    margin:0;\n}\n\ndiv.vbp-widget div.vbp-content div.vbp-category p strong {\n    font-size: 11px;\n    text-transform: uppercase;\n    color: #88A;\n}\n\ndiv.vbp-widget div.vbp-content a:link,\ndiv.vbp-widget div.vbp-content a:visited {\n    color: #35D;\n}\ndiv.vbp-widget div.vbp-content a:hover {\n    color: #000;\n}\n\ndiv.vbp-widget p.vbp-description, div.vbp-widget p.vbp-description-long, div.vbp-widget p.vbp-description-short {\n    padding-top: 2px;\n    padding-bottom: 8px;\n}\n\ndiv.vbp-widget .vbp-description img, div.vbp-widget .vbp-description-long img div.vbp-widget .vbp-description-short img {\n    float: left;\n    border: 1px solid #CCC;\n    margin: 0 8px 8px 0;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news {\n    margin-bottom: 0;\n    padding-bottom: 10px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p {\n    padding-top: 4px;\n    padding-bottom: 4px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a {\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a * { display: block; }\n\ndiv.vbp-widget div.vbp-content .vbp-news p a em {\n    font-size: 10px;\n    text-transform: uppercase;\n    font-style: normal;   \n    color: #666;\n    letter-spacing: 0.08em;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a strong {\n}\ndiv.vbp-widget div.vbp-content .vbp-news p a:hover {\n    text-decoration: none;\n}\ndiv.vbp-widget div.vbp-content .vbp-news p a:hover * {\n    color: #000;\n}\n\ndiv.vbp-widget p.vbp-footer {\n    border-top: 1px solid #CCC;\n    padding: 5px 10px;\n    color: #888;\n    height: 15px;\n    font-size: 11px;\n    text-shadow: 0 1px 1px #FFF;\n}\n\ndiv.vbp-widget .vbp-footer a {\n}\n\ndiv.vbp-widget .vbp-header,\ndiv.vbp-widget .vbp-footer {\n  background: #DDD url(http://venturebeatprofiles.com/images/widget_bg.gif) repeat-x left top;\n}\n\n/**** clearfix ****/\n\n.clearfix:after {\n  content: \'\';\n  display: block;\n  height: 0;\n  clear: both;\n  visibility: hidden;\n }\n\n.tradevibes_hidden, .vbp-hide {\n\tdisplay:none !important;\n}\n</style>\n\n\n\n\n<script type="text/javascript">\n\tvar tv_long_cls = \'vbp-description-long\';\n\tvar tv_short_cls = \'vbp-description-short\';\n\tvar tv_hid = \'vbp-hide tradevibes_hidden\';\n\tfunction tradevibes_toggle_description(e) {\n\t\tvar targ;\n\t\tif (!e) var e = window.event;\n\t\tif (e.target) targ = e.target;\n\t\telse if (e.srcElement) targ = e.srcElement;\n\t\tif (targ.nodeType == 3) // defeat Safari bug\n\t\t\ttarg = targ.parentNode;\n\n\t\tvar parent = targ.parentNode;\n\t\tif (parent.className.indexOf(tv_short_cls) != -1) {\n\t\t\t// short description is visible\n\t\t\tparent.className = tv_hid + \' \' + tv_short_cls;\n\t\t\tvar sibling = parent.nextSibling;\n\t\t\tif (sibling.nodeType == 3) {\n\t\t\t\tsibling = sibling.nextSibling;\n\t\t\t}\n\t\t\tsibling.className = tv_long_cls;\n\t\t}  else {\n\t\t\tparent.className = tv_hid + \' \' + tv_long_cls;\n\t\t\tvar sibling = parent.previousSibling;\n\t\t\tif (sibling.nodeType == 3) {\n\t\t\t\tsibling = sibling.previousSibling;\n\t\t\t}\n\t\t\tsibling.className = tv_short_cls;\n\t\t}\n\t}\n</script>\n\n\n<div class="vbp-widget" id="perlegen-sciences" title="Perlegen Sciences">\n\t<div class="vbp-header">\n\n\t\t<a class="tradevibes_logo vbp-logo " href="http://venturebeatprofiles.com/company/profile/perlegen-sciences?src=widget" title="Perlegen Sciences">\n\t<img src="http://venturebeatprofiles.com/ugenimage/logo/company_4221/16094.png" alt="Perlegen Sciences" title="Perlegen Sciences" width="250" height="22">\n</a>\n\n\n\t\t<p class="vbp-company">\n\t\t\t<a href="http://venturebeatprofiles.com/company/profile/perlegen-sciences?src=widget"><strong>Perlegen Sciences</strong></a>\n\t\t\t<a href="http://www.perlegen.com/" target="_blank"><em>http://www.perlegen.com/</em></a>\n\t\t</p>\n\t\t<p class="vbp-utility">\n\t\t\t<a target="_blank" href="http://venturebeatprofiles.com/account/profile/add_watch/perlegen-sciences?src=widget">Watch Company</a>\n\t\t\t<a target="_blank" href="http://venturebeatprofiles.com/company/widget/preview/perlegen-sciences?src=widget">Get Widget</a>\n\t\t</p>\n\t</div><!-- header -->\n\t<div class="vbp-content clearfix">\n\t\t<div class="vbp-left-col vbp-col">\n\n\t\t\t<p class="vbp-description vbp-description-short tradevibes_short_description">Perlegen conducts genetics research and develops products that impact and improve people\'s lives by employing a proprietary, cost-effective method for rapidly analyzing and comparing entire genomes....<a class="vbp-toggle-more tradevibes_toggle_button discovery_interesting" onclick="tradevibes_toggle_description(event);">More&raquo;</a></p>\n\t\t\t<p class="vbp-description vbp-description-long vbp-hide tradevibes_hidden">Perlegen conducts genetics research and develops products that impact and improve people\'s lives by employing a proprietary, cost-effective method for rapidly analyzing and comparing entire genomes.  This whole genome association study capability enables Perlegen to identify genes that work in concert to cause common diseases and affect the body\'s response to drugs.  Formed in late 2000 as an affiliate of Affymetrix, Inc. (Nasdaq: AFFX), Perlegen is accelerating the development of therapeutics and diagnostics and enabling a new paradigm of high-resolution whole genome scanning.<a class="vbp-toggle-more tradevibes_toggle_button discovery_interesting" onclick="tradevibes_toggle_description(event);">&laquo;Less</a></p>\n\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Overview</h5>\n\t\t\t\t<p><strong>Location:</strong> \tMountain View, CA, United States\n</p>\n\t\t\t\t<p><strong>Industry:</strong> Biopharmaceuticals</p>\n\t\t\t\t<p><strong>Tags:</strong>\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=biotech">biotech</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=therapeutics">therapeutics</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=genetics">genetics</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=Perlegen">Perlegen</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=Research">Research</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=diagnostics">diagnostics</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=genetics+research">genetics research</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=gene">gene</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Financials</h5>\n\t\t\t\t<p><strong>Latest Funding:</strong> Series C - $50M (12/27/2005)</p>\n\t\t\t\t<p><strong>Investors:</strong>\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/bain-capital?src=widget">Bain Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/biofrontier-ventures?src=widget">Biofrontier Ventures</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/brookside-capital?src=widget">Brookside Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/bsi-sa?src=widget">BSI SA</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/cape-securities?src=widget">Cape Securities</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/cmea-ventures?src=widget">CMEA Ventures</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/csk-venture-capital?src=widget">CSK Venture Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/lombard-odier?src=widget">Lombard Odier</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/maverick-capital?src=widget">Maverick Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/mpm-bioequities?src=widget">MPM BioEquities</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/private-life-biomed?src=widget">Private Life Biomed</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/sano-ventures?src=widget">Sano Ventures</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/sbv-life-science-ventures?src=widget">SBV Life Science Ventures</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/zesiger-capital-group?src=widget">Zesiger Capital Group</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/affymetrix?src=widget">Affymetrix</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/eli-lilly?src=widget">Eli Lilly</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/mizuho-securities?src=widget">Mizuho Securities</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/pfizer?src=widget">Pfizer</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/singapore-economic-development-board?src=widget">Singapore Economic Development Board</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/unilever-technology-ventures?src=widget">Unilever Technology Ventures</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\t\t</div><!-- col -->\n\t\t<div class="vbp-right-col vbp-col">\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Market</h5>\n\n\t\t\t\t<p><strong>Related Companies:</strong>\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/epitomics?src=widget">Epitomics</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/investigen?src=widget">Investigen</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/immunomic-therapeutics?src=widget">Immunomic Therapeutics</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/lentigen?src=widget">Lentigen</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/acumen-pharmaceuticals?src=widget">Acumen Pharmaceuticals</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/idiag?src=widget">Idiag</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\n\n\t\t</div><!-- col -->\n\t</div><!-- content -->\n\t<p class="vbp-footer">\n\t\t<a href="http://venturebeatprofiles.com/company/profile/perlegen-sciences?src=widget">Perlegen Sciences Company Profile</a> powered by <a href="http://venturebeatprofiles.com/?src=widget">VentureBeat Profiles</a>.\n\t</p>\n</div><!-- widget -->\n'
);
		  if (typeof tradevibes_post == "function") {
			  tradevibes_post();
		  }
	  }






